These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24929971)

  • 1. Effects of cedar pollen extract on the immune system in vitro.
    Fukushima W; Honda A; Murayama R; Matsuda Y; Tsuji K; Hayashi T; Sawahara T; Ozawa S; Okamoto Y; Takano H
    Allergol Immunopathol (Madr); 2015; 43(2):222-4. PubMed ID: 24929971
    [No Abstract]   [Full Text] [Related]  

  • 2. T-cell activation by transgenic rice seeds expressing the genetically modified Japanese cedar pollen allergens.
    Takaishi S; Saito S; Endo T; Asaka D; Wakasa Y; Takagi H; Ozawa K; Takaiwa F; Otori N; Kojima H
    Immunology; 2019 Oct; 158(2):94-103. PubMed ID: 31323138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of nasal blockage in a Japanese cedar pollen-induced allergic rhinitis model mouse.
    Ogita-Nakanishi H; Nabe T; Mizutani N; Fujii M; Kohno S
    Allergol Int; 2009 Jun; 58(2):171-8. PubMed ID: 19240378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylactic and therapeutic vaccines for Japanese cedar pollinosis].
    Ishii Y
    Nihon Yakurigaku Zasshi; 2010 Jun; 135(6):250-3. PubMed ID: 20543516
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunotherapy for allergic rhinitis induced by Japanese cedar pollens].
    Ohashi Y
    Arerugi; 2008 May; 57(5):519-23. PubMed ID: 18520172
    [No Abstract]   [Full Text] [Related]  

  • 6. A new lipid transfer protein homolog identified as an IgE-binding antigen from Japanese cedar pollen.
    Ibrahim AR; Kawamoto S; Nishimura M; Pak S; Aki T; Diaz-Perales A; Salcedo G; Asturias JA; Hayashi T; Ono K
    Biosci Biotechnol Biochem; 2010; 74(3):504-9. PubMed ID: 20208354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of allergic conjunctivitis in mice by a rice-based edible vaccine containing modified Japanese cedar pollen allergens.
    Fukuda K; Ishida W; Harada Y; Wakasa Y; Takagi H; Takaiwa F; Fukushima A
    Br J Ophthalmol; 2015 May; 99(5):705-9. PubMed ID: 25563761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PS80 interferes with the antiallergic effect of Cry-consensus peptide, a novel recombinant peptide for immunotherapy of Japanese cedar pollinosis, at very low concentration through modulation of Th1/Th2 balance.
    Kozutsumi D; Tsunematsu M; Yamaji T; Murakami R; Yokoyama M; Kino K
    Immunology; 2006 Jul; 118(3):392-401. PubMed ID: 16827900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosis.
    Wakasa Y; Takagi H; Hirose S; Yang L; Saeki M; Nishimura T; Kaminuma O; Hiroi T; Takaiwa F
    Plant Biotechnol J; 2013 Jan; 11(1):66-76. PubMed ID: 23066780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
    Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo inhibitory effects of TLR4 agonist, glucopyranosyl lipid A (GLA), on allergic rhinitis caused by Japanese cedar pollen.
    Matsumoto K; Kouzaki H; Yamamoto S; Kikuoka H; Tojima I; Ter Meulen JH; Shimizu T
    Allergy; 2020 Feb; 75(2):446-449. PubMed ID: 31318982
    [No Abstract]   [Full Text] [Related]  

  • 12. Japanese cedar pollen sublingual immunotherapy is effective in treating seasonal allergic rhinitis during the pollen dispersal period for Japanese cedar and Japanese cypress.
    Yonekura S; Gotoh M; Okano M; Kurokawa T; Maekawa Y; Okubo K; Okamoto Y
    Allergol Int; 2022 Jan; 71(1):140-143. PubMed ID: 34509370
    [No Abstract]   [Full Text] [Related]  

  • 13. Recognition of T cell epitopes unique to Cha o 2, the major allergen in Japanese cypress pollen, in allergic patients cross-reactive to Japanese cedar and Japanese cypress pollen.
    Sone T; Dairiki K; Morikubo K; Shimizu K; Tsunoo H; Mori T; Kino K
    Allergol Int; 2009 Jun; 58(2):237-45. PubMed ID: 19307778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term immunological effects of Japanese cedar pollen-based subcutaneous immunotherapy.
    Inuo C; Ando H; Tanaka K; Nakajima Y; Tsuge I; Urisu A; Kondo Y
    Allergol Int; 2018 Jul; 67(3):408-410. PubMed ID: 29198713
    [No Abstract]   [Full Text] [Related]  

  • 15. A clinical study of Japanese cedar (Cryptomeria japonica) pollen-induced asthma.
    Maeda Y; Akiyama K; Shida T
    Allergol Int; 2008 Dec; 57(4):413-7. PubMed ID: 18946237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Practical guideline for allergic rhinitis 2014 (7th edition): points of revision -prophylactic treatment for cedar pollinosis-].
    Okamoto Y
    Arerugi; 2014 Nov; 63(9):1216-22. PubMed ID: 25492876
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular cloning and immunochemical characterization of a novel major Japanese cedar pollen allergen belonging to the aspartic protease family.
    Ibrahim AR; Kawamoto S; Aki T; Shimada Y; Rikimaru S; Onishi N; Babiker EE; Oiso I; Hashimoto K; Hayashi T; Ono K
    Int Arch Allergy Immunol; 2010; 152(3):207-18. PubMed ID: 20145409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA vaccination against Japanese cedar pollinosis in dogs suppresses type I hypersensitivity by controlling lesional mast cells.
    Masuda K
    Vet Immunol Immunopathol; 2005 Oct; 108(1-2):185-7. PubMed ID: 16098609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking antibody is generated in allergic rhinitis patients during specific immunotherapy using standardized Japanese cedar pollen extract.
    Kawakami A; Koketsu R; Suzukawa M; Nagao M; Hiraguchi Y; Tokuda R; Fujisawa T; Nagase H; Ohta K; Yamamoto K; Yamaguchi M
    Int Arch Allergy Immunol; 2008; 146 Suppl 1():54-60. PubMed ID: 18504408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide immunotherapy for allergic diseases using a rice-based edible vaccine.
    Hiroi T; Takaiwa F
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):455-60. PubMed ID: 17088651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.